BE852095A - Composition pharmaceutique pour le traitement de la leucemie et de tumeurs - Google Patents

Composition pharmaceutique pour le traitement de la leucemie et de tumeurs

Info

Publication number
BE852095A
BE852095A BE175475A BE175475A BE852095A BE 852095 A BE852095 A BE 852095A BE 175475 A BE175475 A BE 175475A BE 175475 A BE175475 A BE 175475A BE 852095 A BE852095 A BE 852095A
Authority
BE
Belgium
Prior art keywords
leukemia
tumors
treatment
pharmaceutical composition
pharmaceutical
Prior art date
Application number
BE175475A
Other languages
English (en)
Original Assignee
Stanford Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Research Inst filed Critical Stanford Research Inst
Publication of BE852095A publication Critical patent/BE852095A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
BE175475A 1976-03-05 1977-03-04 Composition pharmaceutique pour le traitement de la leucemie et de tumeurs BE852095A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66421376A 1976-03-05 1976-03-05

Publications (1)

Publication Number Publication Date
BE852095A true BE852095A (fr) 1977-07-01

Family

ID=24665062

Family Applications (1)

Application Number Title Priority Date Filing Date
BE175475A BE852095A (fr) 1976-03-05 1977-03-04 Composition pharmaceutique pour le traitement de la leucemie et de tumeurs

Country Status (10)

Country Link
JP (1) JPS52120134A (fr)
AU (1) AU511856B2 (fr)
BE (1) BE852095A (fr)
CA (1) CA1085729A (fr)
DE (1) DE2709506C2 (fr)
FR (1) FR2342732A1 (fr)
GB (1) GB1534238A (fr)
IE (1) IE45338B1 (fr)
IL (1) IL51593A (fr)
ZA (1) ZA771315B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393064A (en) * 1976-03-05 1983-07-12 Sri International Process and composition for treatment of leukemia and process for preparing the same
US4460591A (en) * 1982-08-26 1984-07-17 Sri International 8,10-Dideazaminopterins
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
US4833145A (en) * 1986-06-30 1989-05-23 The Trustees Of Princeton University 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives
US4902796A (en) * 1986-10-20 1990-02-20 The Trustees Of Princeton University 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
US5028608A (en) * 1989-12-11 1991-07-02 The Trustees Of Princeton University N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives
US6358953B1 (en) * 1998-10-22 2002-03-19 Phillip B. B. Moheno Pterin antineoplastic agents

Also Published As

Publication number Publication date
IE45338L (en) 1977-09-05
GB1534238A (en) 1978-11-29
JPS613325B2 (fr) 1986-01-31
IL51593A0 (en) 1977-05-31
IL51593A (en) 1980-01-31
IE45338B1 (en) 1982-08-11
ZA771315B (en) 1978-05-30
CA1085729A (fr) 1980-09-16
FR2342732A1 (fr) 1977-09-30
JPS52120134A (en) 1977-10-08
AU2292677A (en) 1978-09-07
FR2342732B1 (fr) 1980-02-01
DE2709506C2 (de) 1987-03-26
DE2709506A1 (de) 1977-09-08
AU511856B2 (en) 1980-09-11

Similar Documents

Publication Publication Date Title
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
FR2338687A1 (fr) Endoscope pour le traitement de strictions uretrales
FR2335885A1 (fr) Structure d'aeration pour aeronef
BE843359A (fr) Preparation pour le traitement de parodontose
BE884917A (fr) Agent pour le traitement de theilerioses et son application
BE849416A (fr) Composition anti-moussage pour le traitement de denrees alimentaires
BE839682A (fr) Procede de preparation de trihydrate d'amoxicilline
BE837662A (fr) Composition gelifiee contenant de la tretinoine pour le traitement de l'acne
BE852095A (fr) Composition pharmaceutique pour le traitement de la leucemie et de tumeurs
FR2306710A1 (fr) Composition pour le traitement du colon
BE851775A (fr) Composition pour le traitement de la chevelure
FR2305416A1 (fr) Procede de preparation de tricosene-(9) et d'heneicosene-(9)
FR2277591A1 (fr) Composition pharmaceutique pour la prevention et le traitement de l'alcoolisme
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE858692A (fr) Composition pour le traitement de l'acne
BE858806A (fr) Procede pour la preparation de glycol-aldehyde et d'ethylene-glycol
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
FR2326189A2 (fr) Composition pharmaceutique
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
BE854412A (fr) Compositions pharmaceutiques pour un traitement gynecologique
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
RO65965A2 (fr) Composition medicamenteuse pour le traitement d'ulcere gastroduodenel
BE860239A (fr) Preparation medicinale pour le traitement des neoformations malignes

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: STANFORD RESEARCH INSTITUTE

Effective date: 19970304